Digbi Health launches Digbi Digestive™, the first gut microbiome and genetic-based digital care program to address IBS and functional digestive disorders affecting 70M Americans.
/Digbi Digestive was launched based on a recent real-world outcomes study of members reversing digestive disorders.
MOUNTAIN VIEW, Calif. – June 16, 2021 – Overwhelming research now links gut microbiome to mental health, sleep disorders, chronic pain, inflammatory digestive and skin illnesses along with chronic lifestyle illnesses including diabetes and obesity.
Digbi Health, the first company with a clinically proven digital genetics and gut-microbiome therapeutic platform program launches Digbi Digestive, a precision care program designed to improve, reverse and monitor gastrointestinal and functional bowel disorders by prescribing food and lifestyle as medicine. Many functional gastrointestinal disorders disproportionately impact women and Caucasians.
Digbi Digestive starts with analyzing a member’s genetics, gut microbiome, meals, habits, clinical markers of sugar and fat in the blood, to isolate inflammatory interactions and develop deeper understanding of metabolic pathways supported by the gut microbiome like serotonin production which regulates sleep and mental health. Members have direct access to gastrointestinal health trained health coaches for personal nutrition support and guidance with meal planning. The program includes live coaching sessions for managing cravings, stress, and sleep. Members can additionally access ongoing gut microbiome monitoring services and personalized prebiotics.